{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T08:00:22Z","timestamp":1785139222570,"version":"3.55.0"},"reference-count":42,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":207,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Breast Journal"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>It is estimated that 5%\u201310% of patients who develop breast cancer have a causative inherited pathogenic or likely pathogenic variant (P\/LP variant). In 2020, the UK National Test Directory published criteria for mainstream genetic testing for breast cancer patients (R208) and, subsequently, eligibility criteria to determine which patients are eligible for gene testing and PARP inhibitor treatment (R444.1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the clearly defined criteria from NHS genomics, eligibility for testing under R208\/R444.1 was determined for all patients diagnosed with breast cancer between March 2021 and March 2025. Eligible patients were offered genetic testing. Incidence of P\/LP variants and impact on treatment were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1812 patients had new DCIS\/invasive breast cancer diagnoses, 255 were eligible for testing and 196 consented. Of these, 28 patients (14.3%) had a P\/LP variant. Eight of these patients were eligible only using family history criteria. Twenty\u2010one patients were eligible for breast conservation surgery. Preoperative genetic results were available for 13: eight patients opted for bilateral mastectomy rather than breast conservation. Where results were available postoperatively, three of eight patients who had breast conservation are planning bilateral risk reducing surgery. Three women newly diagnosed with a BRCA variant received a PARP inhibitor. Eligibility assessment for testing was time\u2010consuming for trained clinicians.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>14.3% of patients eligible and tested for a breast cancer\u2013related hereditary P\/LP variant were positive, which aligns with the expected number predicted by Genomics England. Family history scoring is an important element. Positive results were associated with changes in surgical decision\u2010making for 14 women and enabled 3 patients to receive a PARP inhibitor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1155\/tbj\/2657384","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:10:54Z","timestamp":1785136254000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation and Audit of Mainstream Genetic Testing Within a High\u2010Volume UK Breast Unit for Pathogenic Variations Associated With Breast Cancer Using the R208 and R444.1 National Test Directory Criterion"],"prefix":"10.1155","volume":"2026","author":[{"given":"Soraya","family":"Conroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Wyborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamb","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Chatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah","family":"Durston-Rand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaise","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracie","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Hunter-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana","family":"Laban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Dalgliesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6500-2283","authenticated-orcid":false,"given":"Nicola","family":"Laurence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"e_1_2_10_1_2","unstructured":"American Cancer Society Breast Cancer Risk Factors you Cannot Change 2021 https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/risk-and-prevention\/breast-cancer-risk-factors-you-cannot-change.html#:%7E:text=55%20and%20older.- Inheriting%20certain%20gene%20changes the%20BRCA1%20or%20BRCA2%20gene."},{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.0747"},{"key":"e_1_2_10_3_2","volume-title":"Mainstreaming Cancer Susceptibility Gene Testing","author":"Miles T.","year":"2023"},{"key":"e_1_2_10_4_2","volume-title":"Genomic Laboratory Hubs","author":"Frost A.","year":"2025"},{"key":"e_1_2_10_5_2","article-title":"R208 Inherited Breast and Ovarian Cancer","author":"Nhs South West Genomic Medicine Service","year":"2026","journal-title":"Testing pathway overview"},{"key":"e_1_2_10_6_2","volume-title":"National Genomic Test Directory Testing Criteria for Rare and Inherited Disease","author":"Nhs England","year":"2025"},{"key":"e_1_2_10_7_2","volume-title":"Familial Breast Cancer: Classification, Care and Managing Breast Cancer and Related Risks in People With a Family History of Breast Cancer","year":"2013"},{"key":"e_1_2_10_8_2","unstructured":"Uk Cancer Genetics Group UKCGG\/CStAG Statement on Extension of Testing Undertaken Under R444.1 to Include PALB2 2025 https:\/\/www.ukcgg.org\/media\/12749\/ukcgg-cstag-statement-on-extension-of-testing-undertaken-under-r4441-to-include-palb2-final.pdf."},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00686-8"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1308\/rcsann.2024.0029"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1319"},{"key":"e_1_2_10_12_2","volume-title":"Manchester (Evans) Score","author":"McVeigh T.","year":"2025"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2025-110869"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-018-0406-9"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01631"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229999"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01453"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2018.0055"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.09.159"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2005.08.012"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2022.12.001"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.11.943"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2005936"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01761"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02832-2"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02225"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2020.12.024"},{"key":"e_1_2_10_28_2","volume-title":"National Audit of Primary Breast Cancer (NAoPri)","author":"National Cancer Audit Collaborating Centre","year":"2025"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30891-4"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00152-4"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13053-024-00300-9"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"e_1_2_10_33_2","volume-title":"Variant of Uncertain Significance (VUS)","author":"Frost A.","year":"2024"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2021.03.005"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.10110"},{"key":"e_1_2_10_36_2","first-page":"97","article-title":"Cancer Patients who Experienced Diagnostic Genetic Testing for Cancer Susceptibility: Reactions and Behavior After the Disclosure of a Positive Test Result","volume":"11","author":"Bonadona V.","year":"2002","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.10003"},{"key":"e_1_2_10_38_2","volume-title":"Cancer Blogs","author":"Cano D.","year":"2022"},{"key":"e_1_2_10_39_2","unstructured":"RafiI. HaywardJ. andLucassenA. Genomics. Royal College of General Practitioners 2019 https:\/\/www.rcgp.org.uk\/representing-you\/policy-areas\/genomic-position-statement."},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-013-0020-0"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1417"},{"key":"e_1_2_10_42_2","unstructured":"The Association of British Insurers 2025 Code on Genetic Testing and Insurance"}],"container-title":["The Breast Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/tbj\/2657384","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/tbj\/2657384","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/tbj\/2657384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:10:57Z","timestamp":1785136257000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/tbj\/2657384"}},"subtitle":[],"editor":[{"given":"Imtiaz","family":"Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/tbj\/2657384"],"URL":"https:\/\/doi.org\/10.1155\/tbj\/2657384","archive":["Portico"],"relation":{},"ISSN":["1075-122X","1524-4741"],"issn-type":[{"value":"1075-122X","type":"print"},{"value":"1524-4741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2026-01-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2657384"}}